By using this site, you agree to the Privacy Policy and Terms of Use.
Accept
GMJ NewsGMJ NewsGMJ News
  • Latest News
    • GMJ Briefs
  • Podcast & Media
    • Podcast Episodes
    • GMJ Audio
    • GMJ Videos
  • Research Digest
    • New Studies
    • Georgian Research
    • Data & Numbers
  • Policy & Systems
    • Health Policy
    • Quality & Safety
    • Migration & Health
    • Global Health
  • Practice
    • Clinical Updates
    • Case Discussions
    • Pharmacy & Prescribing
    • Ingredients A-Z
  • Perspectives
    • Editorial
    • Explainers
    • Voices
    • Letters
  • GMJ Articles
    • Vol. 1 Issue 2 (2026)
    • Vol. 1 Issue 1 (2026)
    • Pre-Launch Articles (2025)
  • Read the Journal →
  • About GMJ News
Notification Show More
Font ResizerAa
GMJ NewsGMJ News
Font ResizerAa
  • Latest News
    • GMJ Briefs
  • Podcast & Media
    • Podcast Episodes
    • GMJ Audio
    • GMJ Videos
  • Research Digest
    • New Studies
    • Georgian Research
    • Data & Numbers
  • Policy & Systems
    • Health Policy
    • Quality & Safety
    • Migration & Health
    • Global Health
  • Practice
    • Clinical Updates
    • Case Discussions
    • Pharmacy & Prescribing
    • Ingredients A-Z
  • Perspectives
    • Editorial
    • Explainers
    • Voices
    • Letters
  • GMJ Articles
    • Vol. 1 Issue 2 (2026)
    • Vol. 1 Issue 1 (2026)
    • Pre-Launch Articles (2025)
  • Read the Journal →
  • About GMJ News
Follow US
GMJ News > Drugs A-Z > Statin > Atorvastatin

Atorvastatin

GMJ
Last updated: 02/06/2026 14:31
By
Prof. Giorgi Pkhakadze
Share
5 Min Read
SHARE
3 min read|626 words

Atorvastatin: A Comprehensive Drug Profile

What is Atorvastatin?

Atorvastatin is a cholesterol-lowering medication that belongs to a class of drugs called statins, also known as HMG-CoA reductase inhibitors. It is primarily prescribed to reduce elevated cholesterol levels and lower the risk of cardiovascular events such as heart attacks and strokes. Atorvastatin is one of the most widely prescribed medications worldwide for managing dyslipidemia and preventing cardiovascular disease.

Uses

Atorvastatin is approved for several cardiovascular-related conditions:

  • High cholesterol (hypercholesterolemia): Reduces total cholesterol, LDL (“bad”) cholesterol, and triglycerides while modestly increasing HDL (“good”) cholesterol
  • Primary prevention of cardiovascular disease: Prescribed for individuals with multiple risk factors but no existing heart disease to prevent first-time heart attacks and strokes
  • Secondary prevention after cardiovascular events: Used in patients who have already experienced heart attacks, strokes, or other cardiovascular events to prevent future occurrences
  • Familial hypercholesterolemia: Treats genetic conditions that cause severely elevated cholesterol levels from birth
  • Mixed dyslipidemia: Addresses multiple lipid abnormalities including elevated triglycerides and low HDL cholesterol

How it works

Atorvastatin works by blocking an enzyme called HMG-CoA reductase, which plays a crucial role in cholesterol production in the liver. By inhibiting this enzyme, the medication reduces the liver’s ability to manufacture cholesterol, forcing the body to remove cholesterol from the bloodstream to meet cellular needs. This mechanism effectively lowers blood cholesterol levels and has additional benefits for blood vessel health and inflammation reduction.

Side effects

Common side effects include:

Submit Your Paper
GMJ_Submit_Banner
  • Muscle aches and pains (myalgia)
  • Headache
  • Nausea and digestive upset
  • Diarrhea or constipation
  • Joint pain
  • Upper respiratory tract infections
  • Fatigue
  • Elevation in liver enzymes

Serious side effects to watch for:

  • Severe muscle damage (rhabdomyolysis) with dark urine and muscle weakness
  • Liver problems with yellowing of skin or eyes
  • New onset diabetes or worsening blood sugar control
  • Memory problems or confusion
  • Severe allergic reactions

Warnings and precautions

  • Liver disease: Patients with active liver disease or unexplained persistent elevations in liver enzymes should avoid atorvastatin
  • Pregnancy and breastfeeding: Atorvastatin is contraindicated during pregnancy and breastfeeding as cholesterol is essential for fetal development
  • Muscle disorders: Individuals with a history of muscle diseases or unexplained muscle pain should be monitored closely, as statins can increase the risk of muscle-related complications
  • Kidney impairment: Patients with severe kidney disease may require dose adjustments and closer monitoring
  • Age considerations: Elderly patients may be at higher risk for muscle-related side effects and may require lower starting doses

Interactions

Atorvastatin has several important drug interactions that can increase the risk of side effects:

  • Warfarin: May enhance anticoagulant effects, requiring more frequent INR monitoring
  • Cyclosporine: Significantly increases atorvastatin levels, raising the risk of muscle toxicity
  • Clarithromycin and erythromycin: These antibiotics can increase atorvastatin concentrations and muscle damage risk
  • Antifungal medications (itraconazole, ketoconazole): Can dramatically increase statin levels in the blood
  • HIV protease inhibitors: May increase atorvastatin exposure and associated risks
  • Grapefruit juice: Large amounts can increase drug levels and should be limited
  • Gemfibrozil: Combination increases the risk of severe muscle complications
  • Digoxin: Atorvastatin may increase digoxin levels, requiring monitoring

Check interactions with the GMJ Interaction Checker

Dosage

Typical adult dosing ranges from 10 mg to 80 mg once daily, usually taken in the evening. Most patients start with 20 mg daily, with adjustments made based on cholesterol response and tolerability. For primary prevention, doses of 20-40 mg daily are commonly used, while secondary prevention may require 40-80 mg daily. Patients with familial hypercholesterolemia may need higher doses up to the maximum of 80 mg daily. Dosage should always be individualized and determined by a healthcare provider based on patient-specific factors, cholesterol goals, and cardiovascular risk profile.

Sources: FDA DailyMed drug labels (public domain), BNF, WHO Essential Medicines List. This article is for informational purposes only and does not constitute medical advice. Always consult your healthcare provider before starting or stopping any medication.

Cite this page

GMJ News Desk. "Atorvastatin." GMJ News — Georgian Medical Journal, 1 June 2026. https://news.gmj.ge/drug/atorvastatin-4/

CC BY 4.0This work is licensed under Creative Commons Attribution 4.0 International (CC BY 4.0). You are free to share and adapt this content with attribution to GMJ News (news.gmj.ge).

Was this article helpful?

Related topics

Optional further reading from the GMJ knowledge base.

AtorvastatinDrug AtorvastatinDrug AtorvastatinDrug AtorvastatinDrug AtorvastatinDrug
Share This Article
Facebook LinkedIn Bluesky Copy Link Print
GMJ
ByProf. Giorgi Pkhakadze
Follow:
Prof. Giorgi Pkhakadze, MD, MPH, PhD, is Editor-in-Chief of the Georgian Medical Journal and Chair of the Public Health Institute of Georgia (PHIG). He is Professor and Head of the Department of Social and Behavioural Sciences at David Tvildiani Medical University, and Secretary/Treasurer of the UEMS Section of Public Health. ORCID: 0000-0001-7609-4515.

Submit Your Paper →

Georgia's peer-reviewed open-access medical journal. No APC until January 2027.
Submit Manuscript →
How amino acids shape brain function: neurotransmitters, energy, and cognitive resilience

Amino acids are the precursors to neurotransmitters and metabolic substrates for brain…

How Coffee and Tea Reduce Iron Absorption: A Mechanism Explained

Polyphenols in coffee and tea bind non-heme iron in the gut, reducing…

Eggs and Alzheimer’s risk: New evidence from a 15-year study challenges decades of dietary caution

A 15-year study of 39,498 older adults found that eating eggs five…

Submit Your Paper to GMJ

No APC until January 2027.
Submit Manuscript →

You Might Also Like

Simvastatin

By
Prof. Giorgi Pkhakadze
01/06/2026

Lovastatin

By
Prof. Giorgi Pkhakadze
01/06/2026

Simvastatin

By
Prof. Giorgi Pkhakadze
01/06/2026

Rosuvastatin

By
Prof. Giorgi Pkhakadze
01/06/2026
Facebook Twitter Youtube Instagram
Company
  • Privacy Policy
  • Contact US
  • GMJ Journal
  • Submit Manuscript
  • Editorial Team
  • Register at GMJ
  • Terms of Use

Subscribe to GMJ News — Click here

Join Community
© 2026 Georgian Medical Journal (GMJ). Published by the Public Health Institute of Georgia (PHIG). All rights reserved.
Welcome Back!

Sign in to your account

Username or Email Address
Password

Lost your password?

Not a member? Sign Up